Cargando…

COVID-19-related school closing aggravate obesity and glucose intolerance in pediatric patients with obesity

It is important to pay attention to the indirect effects of the social distancing implemented to prevent the spread of coronavirus disease 2019 (COVID-19) pandemic on children and adolescent health. The aim of the present study was to explore impacts of a reduction in physical activity caused by COV...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Eun Sil, Kwon, Yiyoung, Choe, Yon Ho, Kim, Mi Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943757/ https://www.ncbi.nlm.nih.gov/pubmed/33750841 http://dx.doi.org/10.1038/s41598-021-84766-w

Ejemplares similares

Author Correction: COVID-19-related school closing aggravate obesity and glucose intolerance in pediatric patients with obesity
por: Kim, Eun Sil, et al.
Publicado: (2021)

Increased Demand for Therapeutic Drugs in Pediatric Ulcerative Colitis Patients With Extraintestinal Manifestations
por: Kwon, Yiyoung, et al.
Publicado: (2022)

Upper gastrointestinal tract involvement is more prevalent in Korean patients with pediatric Crohn’s disease than in European patients
por: Kim, Eun Sil, et al.
Publicado: (2020)

How has the disease course of pediatric ulcerative colitis changed throughout the biologics era? A comparison with the IBSEN study
por: Kwon, Yiyoung, et al.
Publicado: (2022)

Free antibodies-to-infliximab are biomarker for predicting the effect of dose intensification in pediatric Crohn’s disease patients with secondary loss of response
por: Kim, Eun Sil, et al.
Publicado: (2023)

Therapeutic Lymphatic Embolization in Pediatric Primary Intestinal Lymphangiectasia
por: Kwon, Yiyoung, et al.
Publicado: (2021)

Albumin-to-Globulin Ratio at 1 Year after Anti-Tumor Necrosis Factor α Therapy Can Serve as a Prognostic Biomarker in Pediatric Crohn’s Disease Patients
por: Kim, Eun Sil, et al.
Publicado: (2022)

Cytokine Profile at Diagnosis Affecting Trough Concentration of Infliximab in Pediatric Crohn’s Disease
por: Kwon, Yiyoung, et al.
Publicado: (2022)

Impact of the histologic grade of acute gastrointestinal graft-versus-host disease on outcomes in pediatric patients treated with allogeneic hematopoietic stem cell transplantation
por: Kim, Eun Sil, et al.
Publicado: (2023)

Efficacy of Combined Initial Treatment of Methotrexate with Infliximab in Pediatric Crohn’s Disease: A Pilot Study
por: Kim, Yoon-Zi, et al.
Publicado: (2023)

Individual approach for treatment of primary intestinal lymphangiectasia in children: single-center experience and review of the literature
por: Kwon, Yiyoung, et al.
Publicado: (2021)

Stratification by Non-invasive Biomarkers of Non-alcoholic Fatty Liver Disease in Children
por: Kwon, Yiyoung, et al.
Publicado: (2022)

Vedolizumab Is Safe and Efficacious for the Treatment of Pediatric-Onset Inflammatory Bowel Disease Patients Who Fail a Primary Biologic Agent
por: Choi, Sujin, et al.
Publicado: (2022)

Comparison of Ustekinumab Trough Concentrations Measured by 2 ELISA Kits and Evaluation of Clinical Response in Crohn’s Disease
por: Kwon, Yiyoung, et al.
Publicado: (2022)

Discontinuation of Azathioprine could be considered in pediatric patients with Crohn’s disease who have sustained clinical and deep remission
por: Jeong, Tae Jong, et al.
Publicado: (2022)

The Identification of a Novel Thiopurine S-Methyltransferase Allele, TPMT*45, in Korean Patient with Crohn’s Disease
por: Ha, Changhee, et al.
Publicado: (2020)

Dual Biological Therapy for Ulcerative Colitis with Intractable Pyoderma Gangrenosum
por: Lee, Hae Chan, et al.
Publicado: (2023)

Increased monocyte abundance as a marker for relapse after discontinuation of biologics in inflammatory bowel disease with deep remission
por: Kwon, Yiyoung, et al.
Publicado: (2022)

Intestinal Ralstonia pickettii augments glucose intolerance in obesity
por: Udayappan, Shanthadevi D., et al.
Publicado: (2017)

The Root of Atractylodes macrocephala Koidzumi Prevents Obesity and Glucose Intolerance and Increases Energy Metabolism in Mice
por: Song, Mi Young, et al.
Publicado: (2018)

Serotonin transporter deficiency drives estrogen-dependent obesity and glucose intolerance
por: Zha, Weibin, et al.
Publicado: (2017)

Pediatric Crohn’s disease with severe morbidity manifested by gastric outlet obstruction: two cases report and review of the literature
por: Kim, Eun Sil, et al.
Publicado: (2021)

Intergenerational Transmission of Glucose Intolerance and Obesity by In Utero Undernutrition in Mice
por: Jimenez-Chillaron, Josep C., et al.
Publicado: (2009)

Correction: Intestinal Ralstonia pickettii augments glucose intolerance in obesity
Publicado: (2018)

Needs for Increased Awareness of Gastrointestinal Manifestations in Patients With Human Inborn Errors of Immunity
por: Kim, Eun Sil, et al.
Publicado: (2021)

Antiretroviral therapy potentiates high-fat diet induced obesity and glucose intolerance
por: Pepin, Mark E., et al.
Publicado: (2018)

Adipocyte CAMK2 deficiency improves obesity-associated glucose intolerance
por: Dai, Wen, et al.
Publicado: (2021)

Oral Limonite Supplement Ameliorates Glucose Intolerance in Diabetic and Obese Mice
por: Uchida, Akihiro, et al.
Publicado: (2021)

Metformin ameliorates olanzapine-induced obesity and glucose intolerance by regulating hypothalamic inflammation and microglial activation in female mice
por: Suh, Sang Bum, et al.
Publicado: (2022)

Control of obesity and glucose intolerance via building neural stem cells in the hypothalamus()
por: Li, Juxue, et al.
Publicado: (2014)

Human Carboxylesterase 2 Reverses Obesity-Induced Diacylglycerol Accumulation and Glucose Intolerance
por: Ruby, Maxwell A., et al.
Publicado: (2017)

Glycine Supplementation in Obesity Worsens Glucose Intolerance through Enhanced Liver Gluconeogenesis
por: Alves, Anaïs, et al.
Publicado: (2022)

Obesity: an asthma aggravating factor?
por: Filho, José Elabras, et al.
Publicado: (2015)

The Associations of Total and Differential White Blood Cell Counts with Obesity, Hypertension, Dyslipidemia and Glucose Intolerance in a Korean Population
por: Kim, Dong-Jun, et al.
Publicado: (2008)

Epiregulin as an Alternative Ligand for Leptin Receptor Alleviates Glucose Intolerance without Change in Obesity
por: Song, No-Joon, et al.
Publicado: (2022)

The crucial role of muscle glucocorticoid signaling in accelerating obesity and glucose intolerance via hyperinsulinemia
por: Yamazaki, Hiroki, et al.
Publicado: (2023)

Free-Living Physical Activity Energy Expenditure Is Strongly Related to Glucose Intolerance in Cameroonian Adults Independently of Obesity
por: Assah, Felix K., et al.
Publicado: (2009)

Prevalence of different states of glucose intolerance in Sri Lankan children and adolescents with obesity and its relation to other comorbidities
por: Ciba, Iris, et al.
Publicado: (2020)

Change in the treatment strategy for pediatric Crohn's disease
por: Kim, Mi Jin, et al.
Publicado: (2010)

Infliximab trough levels are associated with endoscopic healing but not with transmural healing at one year treatment with infliximab in pediatric patients with Crohn’s disease
por: Choi, So Yoon, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_itskh7q7llf306uh8ugqblpbld